Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301 [Phase 3]

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of IN-C006 Peri Inj. compared with RPN301 in parenteral nutrition has completed Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition-related Conditions

Drugs mentioned

• IN-C006 Peri Inj.
• RPN301

Snippet

Sponsor: HK inno.N Corporation | Conditions: Parenteral Nutrition | Phase 3 | Status: COMPLETED